P214 Real-life evaluation of the multi-organ effects of lumacaftor/ivacaftor (Orkambi) on F508del homozygous cystic fibrosis patients

Autor: Yaacoby-Bianu, K., Schnapp, Z., Koren, I., Ilivitzki, A., Shteinberg, M., Livnat, G.
Zdroj: In Journal of Cystic Fibrosis June 2020 19 Supplement 2:S117-S117
Databáze: ScienceDirect